FUNDAMENTALS · Fundamentals · India Healthcare

Inventurus Knowledge Solutions (IKS) Fundamentals 2026 — P/E 42.1x, Revenue Analysis | SniperIQ

Inventurus Knowledge Solutions (IKS) is a India-listed Healthcare company in Medical - Healthcare Information Services with a market capitalization of ₹30,409 Crore, trading at ₹1813.70 on the BSE. This SniperIQ fundamentals page covers Inventurus Knowledge Solutions's valuation (P/E 42.1x, P/B 10.8x), profitability (net margin 22.6%), revenue (₹3,194 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap₹30,409 Crore
P/E (TTM)42.1x
Net Margin22.6%
Revenue (FY26)₹3,194 Crore

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Inventurus Knowledge Solutions's market cap?

Inventurus Knowledge Solutions (IKS) has a market capitalization of approximately ₹30,409 Crore, trading at ₹1813.70 on the BSE. Market cap moves with the live share price.

What is Inventurus Knowledge Solutions's P/E ratio?

Inventurus Knowledge Solutions's trailing twelve-month P/E ratio is 42.1x, with a price-to-book (P/B) of 10.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Inventurus Knowledge Solutions?

Inventurus Knowledge Solutions runs a net profit margin of 22.6%, a gross margin of 34.6%, and an operating margin of 31.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Inventurus Knowledge Solutions generate?

Inventurus Knowledge Solutions reported revenue of ₹3,194 Crore for fiscal year 2026, with net income of ₹722 Crore and earnings per share (EPS) of 43.12. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Inventurus Knowledge Solutions pay a dividend?

Inventurus Knowledge Solutions does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Inventurus Knowledge Solutions financially healthy?

Inventurus Knowledge Solutions carries a debt-to-equity ratio of 0.27x and a current ratio of 1.35x, with a market beta of 0.21. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Inventurus Knowledge Solutions a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Inventurus Knowledge Solutions (IKS) the key facts are: market cap ₹30,409 Crore, P/E 42.1x, revenue ₹3,194 Crore, 52-week range 1262.35-1933.75. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Inventurus Knowledge Solutions's full fundamentals live

Get Inventurus Knowledge Solutions's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Prestige BioPharma (950210) fundamentals · Wockhardt (WOCKPHARMA) fundamentals · Bangkok Dusit Medical Services Public (BDMS) fundamentals · Novartis (NVS) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons